The anti-TNF-alpha effect of the CAP could be used also in the treatment of chronic inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis, in which TNF-α plays a key role [114]. This evidence concerns the gene TNF and ulcerative colitis.